The gene editing technologies market is driven by technological advancements enhancing precision, expanding applications in personalized medicine, and rising genetic disorder prevalence. Despite ...
The market offers strong growth potential driven by advancements in genetic engineering for efficient pharmaceutical protein ...
Technologies needed for tracing engineered biothreats back to their sources are advancing rapidly. Here are some ...
The precision fermentation market presents opportunities in meeting the rising demand for sustainable and animal-free ...
A joint Singaporean-Chinese research team has developed an Evans Blue-modified lipid nanoparticle platform that directs mRNA ...
Topics range from fungal-based building materials and autoimmune diseases to molecular boron chemistry. / €120 million in funding for the first ...
Stoke Therapeutics, Inc. , a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine, and Biogen Inc. today announced data presentations ...
Pharmaceutical Technology on MSN
Potentially “groundbreaking” FDA gene therapy pathway leaves key issues unresolved
A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.
New research on fern vascular systems reveals how developmental constraints don't just limit evolution—they generate new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results